The Minipig As A Model For Juvenile Toxicity Studies

Selecting the right animal model is critical for conducting successful juvenile toxicology studies, as it ensures reliable safety data before progressing to human juvenile trials. The minipig is an exceptional model due to its well-documented development pathway, manageable size, and the close similarity of its tissues and organ systems to those of humans. To help researchers make informed decisions, Altasciences presents “The Minipig as a Model for Juvenile Toxicity Studies,” an on-demand webinar originally delivered at the virtual ACT 2020 Annual Meeting by Dr. Jeff Klein. This webinar provides valuable insights into the role of minipigs in juvenile toxicology, the latest advancements in study designs and endpoints, and practical guidance for selecting the most appropriate animal model for your studies.

About the Presenter
Dr. Jeffrey A. Klein, Ph.D., DABT, is a diplomate of the American Board of Toxicology and a former president of the Society of Toxicology’s Dermal Toxicology Specialty Section. With decades of experience as a study director and program manager at CROs and as a Sponsor leading dermal toxicology programs for pharmaceutical and biotech companies, Dr. Klein brings unmatched expertise in juvenile and dermal toxicology. His background also includes molecular biology, neuroscience, and genetics, making him a leading voice in the field.